Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1602, 2007-01, pp. : 3-3
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Raloxifene most often prescribed for approved indications
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 343, 2001-01 ,pp. :
Access to resources
Recommend
Raloxifene most often prescribed for approved indications
Inpharma, Vol. 1, Iss. 1318, 2001-01 ,pp. :
Improving the safety of newly approved drugs
Inpharma, Vol. 1, Iss. 1337, 2002-01 ,pp. :
Golimumab, adalimumab and etanercept add up for AS
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 643, 2011-01 ,pp. :
A new look at safety for newly approved drugs
Inpharma, Vol. 1, Iss. 1633, 2008-01 ,pp. :